KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.02 $13.63 Friday, 26th Apr 2024 VERV stock ended at $6.16. This is 0.96% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.47% from a day low at $6.02 to a day high of $6.41.
90 days $6.02 $19.34
52 weeks $6.02 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Oct 26, 2023 $9.41 $10.03 $9.35 $9.50 871 334
Oct 25, 2023 $9.50 $9.76 $9.26 $9.35 1 112 785
Oct 24, 2023 $9.37 $9.80 $9.37 $9.56 1 069 457
Oct 23, 2023 $9.72 $9.77 $8.52 $9.17 1 789 152
Oct 20, 2023 $9.48 $9.62 $8.93 $9.28 747 664
Oct 19, 2023 $11.00 $11.08 $9.63 $9.64 1 420 978
Oct 18, 2023 $11.33 $11.50 $10.84 $10.94 644 162
Oct 17, 2023 $11.33 $11.91 $11.33 $11.52 685 255
Oct 16, 2023 $11.68 $11.75 $11.30 $11.57 621 069
Oct 13, 2023 $11.62 $11.81 $11.30 $11.70 502 670
Oct 12, 2023 $12.27 $12.53 $11.37 $11.51 828 153
Oct 11, 2023 $12.59 $12.79 $11.86 $12.27 456 098
Oct 10, 2023 $12.11 $12.90 $12.01 $12.52 594 827
Oct 09, 2023 $12.25 $12.28 $11.76 $12.15 437 024
Oct 06, 2023 $11.83 $12.55 $11.79 $12.44 762 000
Oct 05, 2023 $11.89 $12.35 $11.45 $12.08 1 491 237
Oct 04, 2023 $12.35 $12.35 $11.63 $11.99 754 514
Oct 03, 2023 $11.64 $12.30 $11.39 $12.29 635 228
Oct 02, 2023 $13.10 $13.19 $11.64 $11.78 822 416
Sep 29, 2023 $13.21 $13.47 $12.79 $13.26 965 534
Sep 28, 2023 $12.58 $13.02 $11.85 $12.96 1 255 721
Sep 27, 2023 $13.27 $13.58 $12.41 $12.63 1 063 212
Sep 26, 2023 $11.65 $13.72 $11.50 $12.99 1 518 476
Sep 25, 2023 $12.01 $12.01 $11.25 $11.42 639 192
Sep 22, 2023 $12.57 $12.61 $12.00 $12.09 460 511
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT